Vaginal Estrogen (Topical)
Treatment for Genital prolapse
Typical Dosage: 0.5g applicator 2-3 times/week or vaginal ring/tablet (various doses)
Effectiveness
55%
Safety Score
90%
Clinical Trials
100
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
90
DangerousModerateSafe
Treatment Details
Dosage Range
0.5g applicator 2-3 times/week or vaginal ring/tablet (various doses)
Time to Effect
2-4 weeks
Treatment Duration
Long-term, often lifelong
Evidence Quality
HIGHNumber Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$800
Monitoring:$50
Side Effect Mgmt:$20
Total Annual:$870
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$1,242.86
Prescription Access Economics
Annual Societal Loss per Patient
$735
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$120/year
Time Cost
$45/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$800/year
Potential OTC Price
$250/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWVaginal Estrogen (Topical) Outcomes
for Genital prolapse
Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+70%
Common Side Effects
Vaginal discharge/irritation
+7%
Breast tenderness
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov